Multiple Sclerosis Research

There are numerous projects being conducted at our center and at other centers to look into  better ways to treat multiple sclerosis. These can involve better drugs to alter the immune system or even combinations of drugs that are available now.

Multiple Sclerosis Clinical Trials

• MBP8298 in Subjects with Secondary Progressive Multiple Sclerosis (SPMS)

• Subcutaneous and Intramuscular Natalizumab in Subjects with Multiple Sclerosis (MS)

• MusiQOL to determine EDSS Status Changes in Any Form of Multilple Sclerosis (MS) in Patients With or Without Treatment

• Laqunimod compared to placebo in patients with Relapsing -Remitting Multiple Sclerosis (RRMS)

• Dulozetine HCL in Patients with Central Neuropathic Pain Due to Multiple Sclerosis (MS)

• BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS)

• Ocrelizumab in patients with Relapsing-Remitting Multiple Sclersosis (RRMS)

Related publications by our physicians: Coming soon.

Additional Resources:

National Multiple Sclerosis Society